HF862

Public postsecondary institutions required to maintain a supply of opiate antagonists on system campuses.
Legislative Session 94 (2025-2026)

Related bill: SF164

AI Generated Summary

The proposed bill, authored by Representative Schomacker, mandates that public postsecondary education institutions in Minnesota must keep a supply of opioid antagonists, such as nasal naloxone, on their campuses. Specifically, the bill requires:

  1. Each campus location to maintain a supply of opioid antagonists as outlined in the specified sections of existing Minnesota law.
  2. A minimum of two doses of nasal naloxone available in each campus building.

The bill also directs the Minnesota Commissioner of Health to provide resources, including training materials like videos, to help these institutions implement an opioid antagonist emergency response plan. Furthermore, both the Board of Trustees of the Minnesota State Colleges and Universities and the Board of Regents of the University of Minnesota are encouraged to develop a model plan for the use, storage, and administration of opioid antagonists on their campuses.

This legislative action aims to enhance the safety and preparedness of educational institutions in dealing with opioid-related emergencies, thus safeguarding the health and well-being of students and staff on Minnesota's public postsecondary campuses.

Bill text versions

Showing the most recent version. There are  4  total versions. You must be logged in  to view additional bill text versions.

Actions

DateChamberWhereTypeNameCommittee Name
February 17, 2025HouseActionIntroduction and first reading, referred toHigher Education Finance and Policy
February 24, 2025HouseActionAuthors added
March 12, 2025HouseActionAuthors added
March 17, 2025HouseActionCommittee report, to adopt as amended and re-refer toHealth Finance and Policy
March 27, 2025HouseActionAuthor added
Showing the 5  most recent stages. This bill has 5  stages in total. Log in to view all stages

Citations

You must be logged in  to view citations.

Progress through the legislative process

17%
In Committee

Sponsors

You must be logged in  to view sponsors.

Loading…